No. There is no FDA approved glutathione injection, nasal spray or oral drug product in the United States, for any indication.
That is the short answer, and most pages that give it stop there. The longer answer is more useful, because “not FDA approved” covers several very different regulatory situations and glutathione sits in a specific one that is worth understanding.
This page is general information, not medical advice. Whether glutathione is appropriate for you is a decision for a licensed clinician who has reviewed your health history.
The three states people confuse
| Status | What it means | Glutathione |
|---|---|---|
| FDA approved | A manufacturer ran trials, FDA reviewed safety and effectiveness for a specific indication, and approved a labelled product | No |
| Compoundable under 503A Category 1 | FDA has said it does not intend to act against a compounder using this substance, provided the conditions of section 503A are met | Yes |
| Dietary supplement | Sold without drug approval, not intended for injection, not held to injectable manufacturing standards | Yes, orally. This is the source of a serious problem, covered below |
So glutathione is simultaneously not an approved drug, legally compoundable by prescription, and widely sold as a supplement. All three at once. That is why the internet cannot agree on the answer.
What Category 1 actually means
FDA maintains a list of bulk drug substances nominated for use in compounding under section 503A of the Federal Food, Drug, and Cosmetic Act, sorted into three categories.
- Category 1. Sufficient supporting information, no identified safety risk of the kind that would trigger enforcement. FDA has stated it does not intend to take action against a compounder for compounding with these substances when the other 503A conditions are met.
- Category 2. Safety risks identified. FDA has said it would consider taking action.
- Category 3. Insufficient information nominated to evaluate it at all.
Glutathione is in Category 1. So is NAD. That places both on the more permissive side of the list, which is not true of many substances marketed alongside them in the longevity space. Our running record of where each one sits is on the FDA compounding status tracker, and the parallel question for NAD is answered in is NAD+ FDA approved.
What Category 1 does not mean, and this is the part that gets oversold: it is not a finding of effectiveness. FDA has not evaluated whether glutathione works for anything. It has evaluated whether it is acceptable for a pharmacy to compound.
Where FDA has actively raised concerns
Category 1 status has not stopped the agency from warning about how glutathione is being made.
In August 2026 FDA published a reminder that “Compounders are responsible for ensuring all components used in injectable drugs are appropriate for their intended use and should not use dietary supplement grade ingredients when making injectable drugs.”
The concern it described: “Ingredients labeled for dietary supplement use may contain impurities and contaminants, including endotoxins, that may be harmful when administered as an injectable drug.” FDA reported at least 30 patients with adverse events after IV glutathione compounded from a supplement grade lot, including “fever, chills, pain, dizziness, signs of shock and sepsis-like symptoms, with some resulting in hospitalizations.” It also noted it had raised the same issue in 2019.
Two nationwide recalls of compounded Glutathione Injection 200 mg/mL multi-dose vials followed in August 2026, from Optimal Balance Pharmacy on 19 August and separately from Victory Medical Center Pharmacy, both for elevated bacterial endotoxin found in testing.
FDA advised healthcare professionals to “check with their compounders regarding the source of the glutathione used to make injectable drugs for their patients.” Full detail is in glutathione side effects and the sourcing question.
Separately, FDA has warned consumers about injectable products marketed for skin lightening, which is the use glutathione is most heavily promoted for internationally.
So is it legal?
Compounded glutathione prepared by a licensed pharmacy for an individual patient, on a valid prescription from a clinician licensed in that patient’s state, is operating within the 503A pathway. That is different from buying a vial online without a prescription, and different again from a supplement labelled for oral use being drawn into a syringe, which is the practice FDA wrote the August 2026 reminder about.
This is a description of the regulatory landscape, not legal advice.
What to take from this
- Not FDA approved, and no one should tell you otherwise.
- Legally compoundable, in the most permissive FDA category, which is a genuinely better position than many longevity substances hold.
- Approval status says nothing about whether it works. The evidence question is separate and is covered in the glutathione therapy guide.
- The manufacturing question is not academic. Ask what grade is used and which pharmacy compounds it.
Sources
Every quotation attributed to the FDA on this page is taken from the documents below. Follow the links and check them.
- FDA, Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act. https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding-under-section-503a-fdc-act
- FDA, FDA reminds compounders not to use dietary supplement grade glutathione for injectables. https://www.fda.gov/drugs/human-drug-compounding/fda-reminds-compounders-not-use-dietary-supplement-grade-glutathione-injectables
- FDA, Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels, 19 August 2026. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/optimal-balance-pharmacy-issues-voluntary-nationwide-recall-certain-lots-compounded-glutathione-200
- FDA, Victory Medical Center Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/victory-medical-center-pharmacy-issues-voluntary-nationwide-recall-certain-lots-compounded
Last reviewed 9 September 2026. Regulatory status in compounding changes. If you are reading this well after that date, check the FDA sources directly rather than relying on this page.
Related reading
- The FDA peptide compounding status tracker, kept current
- Glutathione therapy: the complete guide
- Glutathione injection versus nasal spray
- Glutathione side effects and the sourcing question
- NAD+ therapy: the complete guide
- Sermorelin therapy guide
- BPC-157
- Peptide reconstitution calculator
- NAD+ IV versus injection versus nasal spray
- Sermorelin benefits
Longevity plans from PrescribedRX
PrescribedRX prescribes longevity treatments through clinicians licensed in your state:
- Glutathione Injection. Administered by injection after a provider consultation.
- Glutathione Nasal Spray. A nasal alternative.
- NAD+ Injections. On a schedule set by your provider.
- NAD+ Nasal Spray. A nasal alternative.
- Sermorelin Injections. By prescription after consultation.
Every plan and its current price is on the plans page and the pricing page.
These are compounded preparations. Compounded drugs are not reviewed or approved by the FDA for safety or effectiveness, and treatment outcomes are not guaranteed.
This article is for general information. It is not medical advice and it is not a recommendation for any particular treatment. Whether a treatment is appropriate for you is a decision for a licensed clinician who has reviewed your health history and current medications.
